FORM 11.75    Updated: 05-01-2017 $FORM Last Trade:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
37
FORM 11.75    Updated: 05-01-2017 $FORM
Last Trade: 5/1/2017
Last 11.75   
Open 11.25
Previous Close 11.75
Day High / Low 11.82 / 11.25
Year High / Low 13.15 / 6.48
Volume 918,643
Projected Volume 918643 (255%)
# of Trades / Projected 3,630 / 3,630
Dividend / Yield - / 0.00%
Abnormal Activity NONE
Abnormal Volume ABNORMAL VOLUME
Gap NONE
Candle BULLISH
Volatility Today MEDIUM
Volatility Yesterday HIGH
Price Relativity
From 40 Day High 99%
From 80 Day High 93%
From 150 Day High 93%
From 40 Day Low 111%
From 80 Day Low 111%
From 150 Day Low 136%
Pivot Analysis
Price Pivot $ 11.61
Day Resistance 1 $ 11.96
Day Support 1 $ 11.39
Day Resistance 2 $ 12.18
Day Support 2 $ 11.04
Consolidations
Short Term NO
Medium Term NO
Long Term NO
Volume Indicators
20 Day Avg Vol 359,970
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 393,870
Today / 150 Day Avg Vol ABOVE
Abnormal Volume ABNORMAL VOLUME
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bullish
100 Day Trend bearish
Stochastics neutral
RSI bearish
MACD bearish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today MEDIUM
Volatility Index Yesterday HIGH
10 Day Volatility INCREASING
20 Day Volatility INCREASING
40 Day Volatility INCREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 324

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 223

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 169

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 102

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 144

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 74

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 507

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Emerie.ai: Transforming Customer Experience in FinTech

Updated Category News Views 489

Introducing Emerie.ai Emerie.ai, formerly known as ENACOMM Financial Services, Inc., represents a significant step forward in the FinTech arena. The company has undergone a rebranding to better reflect its core offering—an Intelligent Virtual Assistant (IVA)—which utilizes cutting-edge artificial intelligence technology. As customer service standards continue to rise,...

Continue Reading
Explore the Groundbreaking JumpCloudLand Conference 2026

Updated Category News Views 183

JumpCloudLand Conference: A New Era for IT Professionals JumpCloud Inc. has launched a remarkable initiative—JumpCloudLand, a comprehensive virtual conference tailored for IT professionals. This dynamic event is set to take place on February 10, 2026, providing a unique opportunity for IT leaders globally to gather and enhance their skills. The nature of IT is...

Continue Reading
General Shale Introduces an Innovative Brick Collection for 2026

Updated Category News Views 220

Innovative Brick Collection from General Shale for 2026 Transforming Spaces with Stylish Brick Designs For years, clay brick has symbolized durability and tradition. General Shale is now revolutionizing brickwork by introducing a new collection that transforms brick into a modern art form, showcasing a range of sizes, textures, and colors. Their contemporary lineup...

Continue Reading
Revolutionary Breakthrough in Gene Therapy for SCN2A Disorders

Updated Category News Views 269

Groundbreaking Research at UCSF Offers New Hope The laboratories led by Dr. Kevin Bender and Dr. Nadav Ahituv have made significant strides in gene therapy through groundbreaking research. Their recent study unveils a compelling new approach to address SCN2A haploinsufficiency, a critical factor linked to various neurodevelopmental disorders and early-onset epilepsy. This...

Continue Reading
FirstEnergy's New Leadership: Brian Tierney Takes Charge

Updated Category News Views 476

FirstEnergy Corporation Welcomes Brian Tierney as Chair FirstEnergy Corp. (NYSE: FE) has announced the appointment of its President and Chief Executive Officer, Brian X. Tierney, as the new Chair of the Board. This change takes effect on a future date, bringing fresh leadership to the company valued at $22.6 billion. Tierney, who has been in the role of President and CEO...

Continue Reading